Literature DB >> 2216462

Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization.

L Chen1, J P O'Bryan, H S Smith, E Liu.   

Abstract

Genetic alterations are involved in the development of human breast cancer. We sought to isolate genes that are differentially expressed or suppressed in cultured human breast carcinoma cells as compared to cultured normal human breast epithelial cells by employing differential screening of selected cDNA libraries. Analysis of several clones thus isolated revealed that the matrix Gla protein (MGP) gene is overexpressed in the breast cancer cell line 600 PEI, though is transcribed at lower levels in most other mammary derived cultures. MGP requires vitamin K dependent gamma-carboxylation for its known function and thus can be inhibited by vitamin K antagonists. This raises the possibility that MGP may be among those factors that when inhibited by vitamin K antagonists reduce metastases in experimental models. Among the gene whose transcription is consistently suppressed upon mammary transformation were fibronectin and the type I keratin, K14. Differential cDNA screening therefore is an effective method of identifying genes involved in various aspects of mammary cell transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216462

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Total chemical synthesis of human matrix Gla protein.

Authors:  T M Hackeng; J Rosing; H M Spronk; C Vermeer
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 2.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

3.  Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene.

Authors:  J Kirfel; M Kelter; L M Cancela; P A Price; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment.

Authors:  Dalia Barkley; Reuben Moncada; Maayan Pour; Deborah A Liberman; Ian Dryg; Gregor Werba; Wei Wang; Maayan Baron; Anjali Rao; Bo Xia; Gustavo S França; Alejandro Weil; Deborah F Delair; Cristina Hajdu; Amanda W Lund; Iman Osman; Itai Yanai
Journal:  Nat Genet       Date:  2022-08-05       Impact factor: 41.307

5.  Identification of genes specifically regulated in human melanoma cells.

Authors:  J Eberle; C Garbe; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Defining the genomic signature of the parous breast.

Authors:  Suraj Peri; Ricardo López de Cicco; Julia Santucci-Pereira; Michael Slifker; Eric A Ross; Irma H Russo; Patricia A Russo; Alan A Arslan; Ilana Belitskaya-Lévy; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Åhman; Yelena Afanasyeva; Robert Johansson; Fathima Sheriff; Göran Hallmans; Paolo Toniolo; Jose Russo
Journal:  BMC Med Genomics       Date:  2012-10-11       Impact factor: 3.063

7.  Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival.

Authors:  B Newman; L I Gigout; L Sudre; M E Grant; G A Wallis
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

8.  Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.

Authors:  Sonja Mertsch; Leon J Schurgers; Kathrin Weber; Werner Paulus; Volker Senner
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

9.  Matrix gla protein binds to fibronectin and enhances cell attachment and spreading on fibronectin.

Authors:  Satoru Ken Nishimoto; Miyako Nishimoto
Journal:  Int J Cell Biol       Date:  2014-08-21

Review 10.  Matrix Gla protein in tumoral pathology.

Authors:  Simona Roxana Gheorghe; Alexandra Mărioara Crăciun
Journal:  Clujul Med       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.